# catalytic_activity_0019

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `catalytic_activity`  
**Author expected answer:** **D** — S-ubiquitinyl-&#91;E2 ubiquitin-conjugating enzyme&#93;-L-cysteine + &#91;acceptor protein&#93;-L-lysine = &#91;E2 ubiquitin-conjugating enzyme&#93;-L-cysteine + N(6)-ubiquitinyl-&#91;acceptor protein&#93;-L-lysine.

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MPVILNFSSERVLSESELEALRHVGRVSQSEQLVVRGRTMRLHHISFMDSFSVEPVSGGLLDRLSARGHRLLAENLEIQLNRGHTFLQAFRLYMEQSRATPCTRQNVSSAIQNKINSHAFTVSHQDFSCHEQHLNCPITLCIPETGVFVRNAKNSEICSLYDHNALTELIRRNAPHPLSREPFVPEMIVSKDECHFNLIEQYFCILATQNICTRI

[Multiple Choices]
A. tyramine + reduced [NADPH--hemoprotein reductase] + O2 = dopamine + oxidized [NADPH--hemoprotein reductase] + H2O + H(+)
B. 3,4-dihydroxy-5-methoxyphenethylamine + S-adenosyl-L-methionine = N-methyl-3,4-dihydroxy-5-methoxyphenethylamine + S-adenosyl-L-homocysteine + H(+)
C. D-aspartate + acetyl-CoA = N-acetyl-D-aspartate + CoA + H(+)
D. S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzymatic Reaction Prediction, which is to identify the specific chemical reaction catalyzed by a given enzyme. This involves understanding the enzyme's function based on its amino acid sequence and then selecting the correct transformation of substrates into products from a list of possible reactions.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the UniProt entry annotated as E3 ubiquitin-protein ligase NleG, whose catalytic activity is the ubiquitin transfer reaction in choice D. The annotation carries an experimental evidence code, though the cited primary study was not independently assessed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The choices describe quite different enzyme activities, but the supplied sequence alone does not provide a sufficiently specific, evident feature to establish that this protein is an E3 ubiquitin ligase and distinguish choice D.


**Missing item-specific fact**

> The protein-specific functional annotation or equivalent experimental evidence identifying this sequence as NleG and linking it to ubiquitin transfer.


**Reason**

> Selecting D depends on knowing the identity or function of this particular protein, which is not given in the question. Recognizing the sequence from an external database would be lookup or memorization, not reasoning from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The documented catalytic activity for the sequence matches choice D; the other options describe different reactions.


### Important caveats

- The matched UniProt annotations support the key, but their evidence code and cited reference do not by themselves constitute an independent review of the primary experimental results.
- The database identity and annotation are reviewer-only evidence and were absent from the evaluated input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The choices describe quite different enzyme activities, but the supplied sequence alone does not provide a sufficiently specific, evident feature to establish that this protein is an E3 ubiquitin ligase and distinguish choice D.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional annotation or equivalent experimental evidence identifying this sequence as NleG and linking it to ubiquitin transfer.",
    "reason": "Selecting D depends on knowing the identity or function of this particular protein, which is not given in the question. Recognizing the sequence from an external database would be lookup or memorization, not reasoning from the supplied input."
  },
  "case_id": "catalytic_activity_0019",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the UniProt entry annotated as E3 ubiquitin-protein ligase NleG, whose catalytic activity is the ubiquitin transfer reaction in choice D. The annotation carries an experimental evidence code, though the cited primary study was not independently assessed here."
  },
  "important_caveats": [
    "The matched UniProt annotations support the key, but their evidence code and cited reference do not by themselves constitute an independent review of the primary experimental results.",
    "The database identity and annotation are reviewer-only evidence and were absent from the evaluated input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The documented catalytic activity for the sequence matches choice D; the other options describe different reactions."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "catalytic_activity_0019",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the UniProt entry annotated as E3 ubiquitin-protein ligase NleG, whose catalytic activity is the ubiquitin transfer reaction in choice D. The annotation carries an experimental evidence code, though the cited primary study was not independently assessed here.",
    "evidence_ids": ["C1", "C4", "C5", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The choices describe quite different enzyme activities, but the supplied sequence alone does not provide a sufficiently specific, evident feature to establish that this protein is an E3 ubiquitin ligase and distinguish choice D.",
    "missing_item_specific_fact": "The protein-specific functional annotation or equivalent experimental evidence identifying this sequence as NleG and linking it to ubiquitin transfer.",
    "reason": "Selecting D depends on knowing the identity or function of this particular protein, which is not given in the question. Recognizing the sequence from an external database would be lookup or memorization, not reasoning from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The documented catalytic activity for the sequence matches choice D; the other options describe different reactions."
  },
  "important_caveats": [
    "The matched UniProt annotations support the key, but their evidence code and cited reference do not by themselves constitute an independent review of the primary experimental results.",
    "The database identity and annotation are reviewer-only evidence and were absent from the evaluated input."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches UniProt Q8XAN6 (NLEG8_ECO57), annotated as 'E3 ubiquitin-protein ligase NleG' with EC 2.3.2.27. The catalytic activity annotation (C5, H4) explicitly states the reaction in option D. The evidence code is ECO:0000269 (PubMed:36511702), indicating experimental support. Sequence match is exact (215 aa, SHA-256 identical).

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H2](#evidence-h2), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Negative reasoning can weakly eliminate some options: no P450 heme-binding motif (FxxGxRxCxG) argues against A; no Rossmann-fold SAM-binding motif argues against B; no GNAT or other acetyltransferase motif argues against C. However, positively identifying this 215-aa bacterial protein as a U-box E3 ubiquitin ligase (NleG family) requires recognizing the specific U-box fold architecture (a pseudo-RING domain at the C-terminus with modified zinc-binding cysteine spacing and a catalytic glutamine), which is not a canonical, easily recognizable catalytic motif from sequence alone.


**Missing item-specific fact**

> Knowledge that this specific 215-aa E. coli O157:H7 protein is NleG8, a type III secretion system effector with a C-terminal U-box domain functioning as an E3 ubiquitin ligase, or recognition of the non-canonical U-box fold (distinct from standard RING C3HC4 or HECT catalytic cysteine motifs) from primary sequence.


**Reason**

> While the small size, bacterial pathogen origin, and presence of C-terminal cysteines provide weak circumstantial hints, the U-box domain lacks the canonical RING (C3HC4) or HECT (catalytic Cys in a specific context) signatures. Definitively assigning E3 ubiquitin ligase activity to this sequence over the other three enzyme classes requires prior knowledge of the NleG/U-box family or its database annotation, rather than generalizable sequence-to-function reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent very different enzyme classes (P450 monooxygenase, methyltransferase, acetyltransferase, E3 ligase). The absence of motifs characteristic of A, B, and C, combined with the presence of C-terminal cysteine clusters loosely reminiscent of a modified zinc-binding domain, makes D the most plausible choice by elimination. No other option is seriously defensible.


### Important caveats

- The annotation evidence (ECO:0000269, PubMed:36511702) is experimental but the U-box E3 ligase mechanism of NleG proteins was established relatively recently; the protein was originally characterized as a T3SS effector before its ligase activity was confirmed.
- The U-box domain in NleG proteins is a pseudo-RING that has lost canonical zinc coordination; standard RING-detection heuristics would not flag this sequence.
- Reviewer-only evidence was absent from the evaluated model input; the model must rely solely on the 215-aa sequence and the four reaction choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Negative reasoning can weakly eliminate some options: no P450 heme-binding motif (FxxGxRxCxG) argues against A; no Rossmann-fold SAM-binding motif argues against B; no GNAT or other acetyltransferase motif argues against C. However, positively identifying this 215-aa bacterial protein as a U-box E3 ubiquitin ligase (NleG family) requires recognizing the specific U-box fold architecture (a pseudo-RING domain at the C-terminus with modified zinc-binding cysteine spacing and a catalytic glutamine), which is not a canonical, easily recognizable catalytic motif from sequence alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Knowledge that this specific 215-aa E. coli O157:H7 protein is NleG8, a type III secretion system effector with a C-terminal U-box domain functioning as an E3 ubiquitin ligase, or recognition of the non-canonical U-box fold (distinct from standard RING C3HC4 or HECT catalytic cysteine motifs) from primary sequence.",
    "reason": "While the small size, bacterial pathogen origin, and presence of C-terminal cysteines provide weak circumstantial hints, the U-box domain lacks the canonical RING (C3HC4) or HECT (catalytic Cys in a specific context) signatures. Definitively assigning E3 ubiquitin ligase activity to this sequence over the other three enzyme classes requires prior knowledge of the NleG/U-box family or its database annotation, rather than generalizable sequence-to-function reasoning."
  },
  "case_id": "catalytic_activity_0019",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H1",
      "H2",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The sequence matches UniProt Q8XAN6 (NLEG8_ECO57), annotated as 'E3 ubiquitin-protein ligase NleG' with EC 2.3.2.27. The catalytic activity annotation (C5, H4) explicitly states the reaction in option D. The evidence code is ECO:0000269 (PubMed:36511702), indicating experimental support. Sequence match is exact (215 aa, SHA-256 identical)."
  },
  "important_caveats": [
    "The annotation evidence (ECO:0000269, PubMed:36511702) is experimental but the U-box E3 ligase mechanism of NleG proteins was established relatively recently; the protein was originally characterized as a T3SS effector before its ligase activity was confirmed.",
    "The U-box domain in NleG proteins is a pseudo-RING that has lost canonical zinc coordination; standard RING-detection heuristics would not flag this sequence.",
    "Reviewer-only evidence was absent from the evaluated model input; the model must rely solely on the 215-aa sequence and the four reaction choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent very different enzyme classes (P450 monooxygenase, methyltransferase, acetyltransferase, E3 ligase). The absence of motifs characteristic of A, B, and C, combined with the presence of C-terminal cysteine clusters loosely reminiscent of a modified zinc-binding domain, makes D the most plausible choice by elimination. No other option is seriously defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "catalytic_activity_0019",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches UniProt Q8XAN6 (NLEG8_ECO57), annotated as 'E3 ubiquitin-protein ligase NleG' with EC 2.3.2.27. The catalytic activity annotation (C5, H4) explicitly states the reaction in option D. The evidence code is ECO:0000269 (PubMed:36511702), indicating experimental support. Sequence match is exact (215 aa, SHA-256 identical).",
    "evidence_ids": ["C1", "C4", "C5", "H1", "H2", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Negative reasoning can weakly eliminate some options: no P450 heme-binding motif (FxxGxRxCxG) argues against A; no Rossmann-fold SAM-binding motif argues against B; no GNAT or other acetyltransferase motif argues against C. However, positively identifying this 215-aa bacterial protein as a U-box E3 ubiquitin ligase (NleG family) requires recognizing the specific U-box fold architecture (a pseudo-RING domain at the C-terminus with modified zinc-binding cysteine spacing and a catalytic glutamine), which is not a canonical, easily recognizable catalytic motif from sequence alone.",
    "missing_item_specific_fact": "Knowledge that this specific 215-aa E. coli O157:H7 protein is NleG8, a type III secretion system effector with a C-terminal U-box domain functioning as an E3 ubiquitin ligase, or recognition of the non-canonical U-box fold (distinct from standard RING C3HC4 or HECT catalytic cysteine motifs) from primary sequence.",
    "reason": "While the small size, bacterial pathogen origin, and presence of C-terminal cysteines provide weak circumstantial hints, the U-box domain lacks the canonical RING (C3HC4) or HECT (catalytic Cys in a specific context) signatures. Definitively assigning E3 ubiquitin ligase activity to this sequence over the other three enzyme classes requires prior knowledge of the NleG/U-box family or its database annotation, rather than generalizable sequence-to-function reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent very different enzyme classes (P450 monooxygenase, methyltransferase, acetyltransferase, E3 ligase). The absence of motifs characteristic of A, B, and C, combined with the presence of C-terminal cysteine clusters loosely reminiscent of a modified zinc-binding domain, makes D the most plausible choice by elimination. No other option is seriously defensible."
  },
  "important_caveats": [
    "The annotation evidence (ECO:0000269, PubMed:36511702) is experimental but the U-box E3 ligase mechanism of NleG proteins was established relatively recently; the protein was originally characterized as a T3SS effector before its ligase activity was confirmed.",
    "The U-box domain in NleG proteins is a pseudo-RING that has lost canonical zinc coordination; standard RING-detection heuristics would not flag this sequence.",
    "Reviewer-only evidence was absent from the evaluated model input; the model must rely solely on the 215-aa sequence and the four reaction choices."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q8XAN6` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 129. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8XAN6.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:25.588356+00:00.  

```json
"Q8XAN6"
```

Source SHA-256: `791e2a8b0c3d1f9c0bb073dd763d0e0b5f78854dc2060aca744568fc452d270b`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8XAN6.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:25.588356+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"36511702","source":"PubMed"}],"value":"2.3.2.27"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"E3 ubiquitin-protein ligase NleG"}}}
```

Source SHA-256: `791e2a8b0c3d1f9c0bb073dd763d0e0b5f78854dc2060aca744568fc452d270b`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8XAN6.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:25.588356+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","reaction":{"ecNumber":"2.3.2.27","evidences":[{"evidenceCode":"ECO:0000269","id":"36511702","source":"PubMed"}],"name":"S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine."}}
```

Source SHA-256: `791e2a8b0c3d1f9c0bb073dd763d0e0b5f78854dc2060aca744568fc452d270b`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8XAN6?format=txt&versions=129)  
**Locator:** `lines 1-14`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 129 / 1.  
**Retrieved:** 2026-11-01T06:28:42.292045+00:00.  

```text
ID   NLEG8_ECO57             Reviewed;         215 AA.
AC   Q8XAN6; A0A0H3JIV3; A0A6M0JK84; Q7AEM3;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   28-JAN-2026, entry version 129.
DE   RecName: Full=E3 ubiquitin-protein ligase NleG {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:36511702};
GN   Name=nleG8 {ECO:0000303|PubMed:36511702};
GN   Synonyms=nleG {ECO:0000312|EMBL:BAB35247.1};
GN   ORFNames=ECs_1824 {ECO:0000312|EMBL:BAB35247.1};
OS   Escherichia coli O157:H7.
OC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;
OC   Enterobacterales; Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83334;
```

Source SHA-256: `6f2c88b76a2a840b2a82d844b183b53e16025dc00931c5f80d6e962d640caabe`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8XAN6?format=txt&versions=129)  
**Locator:** `lines 6-7`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 129 / 1.  
**Retrieved:** 2026-11-01T06:28:42.292045+00:00.  

```text
DE   RecName: Full=E3 ubiquitin-protein ligase NleG {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:36511702};
```

Source SHA-256: `6f2c88b76a2a840b2a82d844b183b53e16025dc00931c5f80d6e962d640caabe`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8XAN6?format=txt&versions=129)  
**Locator:** `lines 50-54`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 129 / 1.  
**Retrieved:** 2026-11-01T06:28:42.292045+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:36511702};
```

Source SHA-256: `6f2c88b76a2a840b2a82d844b183b53e16025dc00931c5f80d6e962d640caabe`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/catalytic_activity.json), zero-based source row 19. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
